sampleID	_EVENT	_INTEGRATION	OS.time	OS	OS.unit	_PATIENT	RFS.time	RFS	RFS.unit	_TIME_TO_EVENT	_TIME_TO_EVENT_UNIT	_cohort	_primary_disease	_primary_site	age_at_initial_pathologic_diagnosis	b_lymphocyte_genotyping_method	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	bone_marrow_biopsy_done	bone_marrow_involvement	bone_marrow_sample_histology	clinical_stage	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_after_initial_treatment	eastern_cancer_oncology_group	ebv_positive_malignant_cells_percent	ebv_status_malignant_cells_method	epstein_barr_viral_status	extranodal_involvement	extranodal_involvment_site_other	extranodal_sites_involvement_number	first_progression_histology_type	first_progression_histology_type_other	first_recurrence_biopsy_confirmed	follicular_percent	followup_case_report_form_submission_reason	followup_treatment_success	form_completion_date	gender	genetic_abnormality_method_other	genetic_abnormality_results	genetic_abnormality_results_other	genetic_abnormality_tested	genetic_abnormality_tested_other	height	histological_type	history_immunological_disease	history_immunological_disease_other	history_immunosuppresive_rx	history_immunosuppressive_rx_other	history_of_neoadjuvant_treatment	history_relevant_infectious_dx	hiv_status	icd_10	icd_o_3_histology	icd_o_3_site	igh_genotype_results	immunophenotypic_analysis_method	immunophenotypic_analysis_results	immunophenotypic_analysis_tested	informed_consent_verified	initial_weight	intermediate_dimension	is_ffpe	ldh_level	ldh_norm_range_upper	longest_dimension	lost_follow_up	lymph_node_involvement_site	maximum_tumor_bulk_anatomic_site	maximum_tumor_dimension	mib1_positive_percentage_range	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_after_initial_treatment	oct_embedded	other_dx	pathology_report_file_name	patient_id	person_neoplasm_cancer_status	pet_scan_results	primary_therapy_outcome_success	radiation_therapy	sample_type	sample_type_id	shortest_dimension	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	vial_number	vital_status	weight	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_DLBC_exp_HiSeqV2	_GENOMIC_ID_TCGA_DLBC_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_DLBC_PDMRNAseq	_GENOMIC_ID_TCGA_DLBC_hMethyl450	_GENOMIC_ID_TCGA_DLBC_miRNA_HiSeq	_GENOMIC_ID_TCGA_DLBC_gistic2thd	_GENOMIC_ID_TCGA_DLBC_PDMRNAseqCNV	_GENOMIC_ID_data/public/TCGA/DLBC/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_DLBC_gistic2	_GENOMIC_ID_TCGA_DLBC_mutation_bcm_gene	_GENOMIC_ID_TCGA_DLBC_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_DLBC_RPPA	_GENOMIC_ID_TCGA_DLBC_exp_HiSeqV2_PANCAN
TCGA-FA-8693-01	0	TCGA-FA-8693-01	132	0	days	TCGA-FA-8693	132	0	days	132	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	75		TCGA-FA-8693-F42020	TCGA-FA-8693	TCGA-FA-8693-01A				Stage I	-27468			0	132						YES		1				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2013-4-9	MALE						169	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C16.9		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Negative|Negative	CD10 > 30%|CD20|CD5|Cyclin D1	YES		1.5	NO			2.8	YES				51 - 75%			NO		No	TCGA-FA-8693.977683b9-1cad-4033-9825-7dbb84b171e1.pdf	8693	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01	0.5	7th	YES	YES	NO	FA	Stomach	A	LIVING	82	2012	74108a37-6306-4389-93c2-b2d306ad6709	74108a37-6306-4389-93c2-b2d306ad6709	TCGA-FA-8693-01	TCGA-FA-8693-01A-11D-2399-05	TCGA-FA-8693-01	TCGA-FA-8693-01A-11D-2389-01	TCGA-FA-8693-01	TCGA-FA-8693-01	TCGA-FA-8693-01A-11D-2389-01	TCGA-FA-8693-01A-11D-2397-10	74108a37-6306-4389-93c2-b2d306ad6709	E80F1E78-0477-4A56-8F2C-CB88B6BB8938	74108a37-6306-4389-93c2-b2d306ad6709
TCGA-FA-A4BB-01	0	TCGA-FA-A4BB-01	132	0	days	TCGA-FA-A4BB	132	0	days	132	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	67		TCGA-FA-A4BB-F49912	TCGA-FA-A4BB	TCGA-FA-A4BB-01A	NO	NO		Stage IV	-24590	97		0	132						YES	Spleen	2				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2013-10-14	MALE						178	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C77.3		Immunohistochemistry|Immunohistochemistry	Positive|Positive	CD20|CD30	YES	1430		NO				YES	Axillary|Inguinal	Axillary lymph nodes	3.5				NO	true	No	TCGA-FA-A4BB.05B34041-D414-4215-9A66-2B7E4D09F4D5.pdf	A4BB	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	YES	NO	FA	Liver|Other Extranodal Site	A	LIVING	85	2012	d4923060-b733-42cb-ab55-b43a2c9a9151	d4923060-b733-42cb-ab55-b43a2c9a9151	TCGA-FA-A4BB-01	TCGA-FA-A4BB-01A-11D-A31Y-05	TCGA-FA-A4BB-01	TCGA-FA-A4BB-01A-11D-A31W-01	TCGA-FA-A4BB-01	TCGA-FA-A4BB-01	TCGA-FA-A4BB-01A-11D-A31W-01	TCGA-FA-A4BB-01A-11D-A31X-10	d4923060-b733-42cb-ab55-b43a2c9a9151	8071470F-41FB-441A-A3EA-43E08333109C	d4923060-b733-42cb-ab55-b43a2c9a9151
TCGA-FA-A4XK-01	1	TCGA-FA-A4XK-01	708	1	days	TCGA-FA-A4XK	708	0	days	708	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	40		TCGA-FA-A4XK-F68091	TCGA-FA-A4XK	TCGA-FA-A4XK-01A				Stage II	-14723	140	708	0	62						YES		1				< or = 10%	Scheduled Follow-up Submission	Progressive Disease	2014-11-21	MALE						165	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C17.1		Immunohistochemistry	Positive	CD20	YES	1370		NO				NO	other	Small Intestine	10				NO	true	No	TCGA-FA-A4XK.05EFF049-BF35-4D89-8968-5442C5FF375A.pdf	A4XK	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01		7th	NO	YES	NO	FA	Small intestine	A	DECEASED	60	2012	95db81b0-d9e6-4cbf-b13f-7c1b92c26484	95db81b0-d9e6-4cbf-b13f-7c1b92c26484	TCGA-FA-A4XK-01	TCGA-FA-A4XK-01A-11D-A31Y-05	TCGA-FA-A4XK-01	TCGA-FA-A4XK-01A-11D-A31W-01	TCGA-FA-A4XK-01	TCGA-FA-A4XK-01	TCGA-FA-A4XK-01A-11D-A31W-01	TCGA-FA-A4XK-01A-11D-A31X-10	95db81b0-d9e6-4cbf-b13f-7c1b92c26484	923E2FAF-6F97-4D7E-983E-6D982490825B	95db81b0-d9e6-4cbf-b13f-7c1b92c26484
TCGA-FA-A6HN-01	1	TCGA-FA-A6HN-01	58	1	days	TCGA-FA-A6HN	58	0	days	58	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	73		TCGA-FA-A6HN-F63567	TCGA-FA-A6HN	TCGA-FA-A6HN-01A	NO				-27025	97	58	0	6						NO						< or = 10%	Scheduled Follow-up Submission	Progressive Disease	2014-8-13	MALE						162	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C77.0		Immunohistochemistry	Positive	CD20	YES	150		NO				NO	cervical	Cervical lymph nodes	1.5				NO	true	No	TCGA-FA-A6HN.8776C20D-275D-4859-86E3-0CE38C5B7912.pdf	A6HN	TUMOR FREE	Not Done	Progressive Disease	NO	Primary Tumor	01		7th	YES	YES	NO	FA		A	DECEASED	58	2013	f6788ba9-322e-49b0-93e4-f1b451f2a985	f6788ba9-322e-49b0-93e4-f1b451f2a985	TCGA-FA-A6HN-01	TCGA-FA-A6HN-01A-11D-A31Y-05	TCGA-FA-A6HN-01	TCGA-FA-A6HN-01A-11D-A31W-01	TCGA-FA-A6HN-01	TCGA-FA-A6HN-01	TCGA-FA-A6HN-01A-11D-A31W-01	TCGA-FA-A6HN-01A-11D-A31X-10	f6788ba9-322e-49b0-93e4-f1b451f2a985	567EC21A-D4DD-493B-BE78-57D4ECBA5A11	f6788ba9-322e-49b0-93e4-f1b451f2a985
TCGA-FA-A6HO-01	0	TCGA-FA-A6HO-01	749	0	days	TCGA-FA-A6HO	739	1	days	749	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	58		TCGA-FA-A6HO-F71473	TCGA-FA-A6HO	TCGA-FA-A6HO-01A	NO				-21330	85		0	749	739					NO					NO	< or = 10%	Scheduled Follow-up Submission	Progressive Disease	2015-3-30	FEMALE						158	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C77.0		Immunohistochemistry	Positive	CD20	YES	140		NO				NO	cervical	Cervical	1.5		Paraaortic lymph nodes		YES	true	No	TCGA-FA-A6HO.E2645414-D707-419D-B43D-92AE9D56DCD1.pdf	A6HO	WITH TUMOR	Not Done	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	YES	NO	FA		A	LIVING	61	2013	52ece957-8f21-4f13-a61d-7b2e1c850ef5	52ece957-8f21-4f13-a61d-7b2e1c850ef5	TCGA-FA-A6HO-01	TCGA-FA-A6HO-01A-11D-A31Y-05	TCGA-FA-A6HO-01	TCGA-FA-A6HO-01A-11D-A31W-01	TCGA-FA-A6HO-01	TCGA-FA-A6HO-01	TCGA-FA-A6HO-01A-11D-A31W-01	TCGA-FA-A6HO-01A-11D-A31X-10	52ece957-8f21-4f13-a61d-7b2e1c850ef5	731E0A85-D8EA-4F5D-9EC4-35131FD15957	52ece957-8f21-4f13-a61d-7b2e1c850ef5
TCGA-FA-A7DS-01	0	TCGA-FA-A7DS-01	719	0	days	TCGA-FA-A7DS	719	0	days	719	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	54		TCGA-FA-A7DS-F71471	TCGA-FA-A7DS	TCGA-FA-A7DS-01A	NO			Stage II	-20087	138		0	719						NO		1				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-30	FEMALE						157	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C50.9	9680/3	C50.9		Immunohistochemistry	Positive	CD20	YES	780		NO				NO	other	Breast	4				NO	true	No	TCGA-FA-A7DS.F36A477E-88C9-476A-BF68-61CA129A30A1.pdf	A7DS	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	YES	NO	FA	Breast	A	LIVING	60	2013	c221049a-13bf-46fa-a049-20b853ea4091	c221049a-13bf-46fa-a049-20b853ea4091	TCGA-FA-A7DS-01	TCGA-FA-A7DS-01A-11D-A383-05	TCGA-FA-A7DS-01	TCGA-FA-A7DS-01A-11D-A381-01	TCGA-FA-A7DS-01	TCGA-FA-A7DS-01	TCGA-FA-A7DS-01A-11D-A381-01	TCGA-FA-A7DS-01A-11D-A382-10	c221049a-13bf-46fa-a049-20b853ea4091	58611192-9423-4830-9281-52DD014102B0	c221049a-13bf-46fa-a049-20b853ea4091
TCGA-FA-A7Q1-01	1	TCGA-FA-A7Q1-01	248	1	days	TCGA-FA-A7Q1	248	0	days	248	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	61		TCGA-FA-A7Q1-F63621	TCGA-FA-A7Q1	TCGA-FA-A7Q1-01A	NO			Stage I	-22454	158	248	0	22						NO						< or = 10%	Scheduled Follow-up Submission		2014-12-11	FEMALE						157	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C48.1	9680/3	C48.1		Immunohistochemistry	Positive	CD20	YES	170		NO				NO	mesenteric	Mesenteric lymph nodes	3				NO	true	No	TCGA-FA-A7Q1.D9C18E71-3D93-4B22-87B7-E5C34CC670C5.pdf	A7Q1	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	YES	NO	FA		A	DECEASED	65	2013	d6edbae7-9967-4bf5-9fcf-433dc71b35f8	d6edbae7-9967-4bf5-9fcf-433dc71b35f8	TCGA-FA-A7Q1-01	TCGA-FA-A7Q1-01A-11D-A383-05	TCGA-FA-A7Q1-01	TCGA-FA-A7Q1-01A-11D-A381-01	TCGA-FA-A7Q1-01	TCGA-FA-A7Q1-01	TCGA-FA-A7Q1-01A-11D-A381-01	TCGA-FA-A7Q1-01A-11D-A382-10	d6edbae7-9967-4bf5-9fcf-433dc71b35f8	C696CE3E-8BAE-4015-ABE2-C4C21E778548	d6edbae7-9967-4bf5-9fcf-433dc71b35f8
TCGA-FA-A82F-01	0	TCGA-FA-A82F-01	427	0	days	TCGA-FA-A82F	427	0	days	427	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	48		TCGA-FA-A82F-F65335	TCGA-FA-A82F	TCGA-FA-A82F-01A	NO			Stage II	-17819	97		0	427						NO		1				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-9-22	FEMALE						157	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C17.9		Immunohistochemistry|Immunohistochemistry	Positive|Positive	CD20|PAX5	YES	580		NO				NO	mesenteric	Small Intestine	6				NO	true	No	TCGA-FA-A82F.9BDF3D5C-8203-4F43-9BE5-8F1F278C124B.pdf	A82F	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	YES	NO	FA	Small intestine	A	LIVING	50	2013	49237a86-9b3c-40ed-8b94-c0a5d9e15c82	49237a86-9b3c-40ed-8b94-c0a5d9e15c82	TCGA-FA-A82F-01	TCGA-FA-A82F-01A-11D-A383-05	TCGA-FA-A82F-01	TCGA-FA-A82F-01A-11D-A381-01	TCGA-FA-A82F-01	TCGA-FA-A82F-01	TCGA-FA-A82F-01A-11D-A381-01	TCGA-FA-A82F-01A-11D-A382-10	49237a86-9b3c-40ed-8b94-c0a5d9e15c82	1379785E-11E5-467C-B727-69C256F1F58E	49237a86-9b3c-40ed-8b94-c0a5d9e15c82
TCGA-FA-A86F-01	0	TCGA-FA-A86F-01	553	0	days	TCGA-FA-A86F	150	1	days	553	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	64		TCGA-FA-A86F-F70699	TCGA-FA-A86F	TCGA-FA-A86F-01A	NO			Stage III	-23641	86		0	553	150					NO					NO	< or = 10%	Scheduled Follow-up Submission	Partial Remission/Response	2015-3-2	FEMALE						156	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					No		Negative	C83.3	9680/3	C77.3		Immunohistochemistry|Immunohistochemistry	Negative|Positive	CD10 > 30%|CD20	YES	510		NO				NO	Axillary		2	26 - 50%	Other, specify	Inguinal, mediastinal, submandibular, hilar	YES	true	No	TCGA-FA-A86F.6D34FB3F-83A5-4B8D-AB2A-76931ED85F9F.pdf	A86F	WITH TUMOR	Not Done	Partial Remission/Response	NO	Primary Tumor	01		7th	YES	YES	NO	FA		A	LIVING	67	2013	a3ca2450-1f4e-4372-bdd4-46f83e2e9602	a3ca2450-1f4e-4372-bdd4-46f83e2e9602	TCGA-FA-A86F-01	TCGA-FA-A86F-01A-11D-A383-05	TCGA-FA-A86F-01	TCGA-FA-A86F-01A-11D-A381-01	TCGA-FA-A86F-01	TCGA-FA-A86F-01	TCGA-FA-A86F-01A-11D-A381-01	TCGA-FA-A86F-01A-11D-A382-10	a3ca2450-1f4e-4372-bdd4-46f83e2e9602	37D2BBC9-18DF-430A-9D98-BD71273FA2F0	a3ca2450-1f4e-4372-bdd4-46f83e2e9602
TCGA-FF-8041-01	0	TCGA-FF-8041-01	1081	0	days	TCGA-FF-8041	1081	0	days	1081	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	28		TCGA-FF-8041-F30778	TCGA-FF-8041	TCGA-FF-8041-01A		NO		Stage I	-10466			0	1081		0				NO						< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2011-12-14	FEMALE	FISH|FISH|	Normal|Normal|Normal|Normal|Normal	Normal|Normal|	C-MYC|BCL2|BCL6|CCND1|MALT1	IGH|PAX5|	173	Primary mediastinal (thymic) DLBCL			None		No		Negative	C38.1	9680/3	C38.1		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD30|Cyclin D1	YES			NO	499	380			mediastinal	mediastinal	12	76 - 100%			NO		No	TCGA-FF-8041.6d6d4023-46b1-41c8-8e41-b19aabe93504.pdf	8041	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	NO	YES	FF		A	LIVING	58.9	2010	40024e0a-a264-4dd8-9138-9a468b9c12ca	40024e0a-a264-4dd8-9138-9a468b9c12ca	TCGA-FF-8041-01	TCGA-FF-8041-01A-11D-2211-05	TCGA-FF-8041-01	TCGA-FF-8041-01A-11D-2209-01	TCGA-FF-8041-01	TCGA-FF-8041-01	TCGA-FF-8041-01A-11D-2209-01	TCGA-FF-8041-01A-11D-2210-10	40024e0a-a264-4dd8-9138-9a468b9c12ca	69683AA1-5878-4F74-BE5A-40A19AF5A9BF	40024e0a-a264-4dd8-9138-9a468b9c12ca
TCGA-FF-8042-01	0	TCGA-FF-8042-01	946	0	days	TCGA-FF-8042	946	0	days	946	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	57		TCGA-FF-8042-F30771	TCGA-FF-8042	TCGA-FF-8042-01A		NO		Stage II	-21005			0	946		0				NO						< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2011-12-14	FEMALE	FISH|FISH|	Normal|Translocation|Normal|Normal|Normal	Normal|Normal|	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|	171	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No	Hepatitis B Virus	Negative	C83.3	9680/3	C77.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD79a|CD5|Cyclin D1	YES			NO	461	380			cervical|supraclavicular	Supraclavicular lymph nodes	1.5	76 - 100%			NO		No	TCGA-FF-8042.6cdcaac9-0654-4bda-8344-ce0b810abb15.pdf	8042	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	NO	YES	FF		A	LIVING	89.9	2010	144739d3-b2d3-493c-8731-d652f03a5b37	144739d3-b2d3-493c-8731-d652f03a5b37	TCGA-FF-8042-01	TCGA-FF-8042-01A-11D-2211-05	TCGA-FF-8042-01	TCGA-FF-8042-01A-11D-2209-01	TCGA-FF-8042-01	TCGA-FF-8042-01	TCGA-FF-8042-01A-11D-2209-01	TCGA-FF-8042-01A-11D-2210-10	144739d3-b2d3-493c-8731-d652f03a5b37	DCF7BA40-E2A3-4FC8-9720-39B6426D2F2F	144739d3-b2d3-493c-8731-d652f03a5b37
TCGA-FF-8043-01	0	TCGA-FF-8043-01	965	0	days	TCGA-FF-8043	965	0	days	965	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	70		TCGA-FF-8043-F30759	TCGA-FF-8043	TCGA-FF-8043-01A		NO		Stage II	-25612			0	965		1				YES		1				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2011-12-14	FEMALE	FISH|FISH|	Normal|Normal|Normal|Normal|Normal	Normal|Normal|	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|	146	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No	Hepatitis B Virus	Negative	C83.3	9680/3	C18.9		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cyclin D1	YES			NO	536	380			mesenteric	Colon	0.4	76 - 100%			NO		No	TCGA-FF-8043.a6785541-7d40-4a2d-b828-19376217866b.pdf	8043	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	NO	YES	FF	Colon	A	LIVING	41.5	2010	f43a92ce-fc88-4e40-be91-0b5641ad844e	f43a92ce-fc88-4e40-be91-0b5641ad844e	TCGA-FF-8043-01	TCGA-FF-8043-01A-11D-2211-05	TCGA-FF-8043-01	TCGA-FF-8043-01A-11D-2209-01	TCGA-FF-8043-01	TCGA-FF-8043-01	TCGA-FF-8043-01A-11D-2209-01	TCGA-FF-8043-01A-11D-2210-10	f43a92ce-fc88-4e40-be91-0b5641ad844e	EB52A17E-5E44-4B21-9192-2A476171C5F8	f43a92ce-fc88-4e40-be91-0b5641ad844e
TCGA-FF-8046-01	0	TCGA-FF-8046-01	751	0	days	TCGA-FF-8046	751	0	days	751	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	51		TCGA-FF-8046-F30762	TCGA-FF-8046	TCGA-FF-8046-01A		NO		Stage II	-18853			0	751		0				NO						< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2011-12-14	MALE	FISH|FISH|FISH|FISH|	Translocation|Normal|Normal|Normal|Normal	Normal|Translocation|Normal|Normal|	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|IGK|IGL|	178	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C08.0	9680/3	C08.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Positive|Positive|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|Cyclin D1	YES			NO	623	380			cervical|Submandibular	Thyroid	4.8	76 - 100%			NO		No	TCGA-FF-8046.78b14526-0c81-4065-8c26-46197a6b2324.pdf	8046	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	YES	NO	FF		A	LIVING	81.9	2011	a0091162-1691-4b4c-990f-c58369e09548	a0091162-1691-4b4c-990f-c58369e09548	TCGA-FF-8046-01	TCGA-FF-8046-01A-11D-2211-05	TCGA-FF-8046-01	TCGA-FF-8046-01A-11D-2209-01	TCGA-FF-8046-01	TCGA-FF-8046-01	TCGA-FF-8046-01A-11D-2209-01	TCGA-FF-8046-01A-11D-2210-10	a0091162-1691-4b4c-990f-c58369e09548	EC8DB612-B2AB-4A29-9150-048BF6E25816	a0091162-1691-4b4c-990f-c58369e09548
TCGA-FF-8047-01	0	TCGA-FF-8047-01	126	0	days	TCGA-FF-8047	24	1	days	126	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	38		TCGA-FF-8047-F30870	TCGA-FF-8047	TCGA-FF-8047-01A		NO		Stage II	-13996			0	126	24	2				NO			Diffuse Large B-Cell Lymphoma		YES	< or = 10%	Additional New Tumor Event	Progressive Disease	2012-1-5	FEMALE	FISH|FISH|	Translocation|Normal|Translocation|Normal|Normal	Normal|Translocation|	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|	155	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No	Hepatitis B Virus	Negative	C83.3	9680/3	C77.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|Cyclin D1	YES			NO	667	380			cervical|Inguinal	Cervical	2.0	76 - 100%	Leptomeninges		YES		No	TCGA-FF-8047.eea72d00-007d-4b3c-8760-889d859674d0.pdf	8047	WITH TUMOR	Positive	Progressive Disease	NO	Primary Tumor	01		7th	YES	YES	NO	FF		A	LIVING	52.5	2011	6fbec533-7f89-4d12-b04c-cf92942c3f33	6fbec533-7f89-4d12-b04c-cf92942c3f33	TCGA-FF-8047-01	TCGA-FF-8047-01A-11D-2211-05	TCGA-FF-8047-01	TCGA-FF-8047-01A-11D-2209-01	TCGA-FF-8047-01	TCGA-FF-8047-01	TCGA-FF-8047-01A-11D-2209-01	TCGA-FF-8047-01A-11D-2210-10	6fbec533-7f89-4d12-b04c-cf92942c3f33	B05EB5CD-1C5B-47C3-80D5-59B0CB5BB3B4	6fbec533-7f89-4d12-b04c-cf92942c3f33
TCGA-FF-8061-01	0	TCGA-FF-8061-01	832	0	days	TCGA-FF-8061	832	0	days	832	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	42		TCGA-FF-8061-F30766	TCGA-FF-8061	TCGA-FF-8061-01A		NO		Stage II	-15358			0	832		0				YES		1				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2012-1-17	MALE	FISH|FISH|	Normal|Normal|Normal|Normal|Normal	Normal|Translocation|	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|	171	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C17.9		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive|Positive|Positive|Positive	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|PAX5	YES		0.6	NO	414	380	0.7		mesenteric	Small Intestine	15	76 - 100%			NO		No	TCGA-FF-8061.9ea8bb70-9001-4ba3-8f3d-6b97af99f875.pdf	8061	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01	0.4	7th	YES	YES	NO	FF	Small intestine	A	LIVING	48.1	2010	953e90e7-a9a6-47d6-bd4a-fe18e780b9e0	953e90e7-a9a6-47d6-bd4a-fe18e780b9e0	TCGA-FF-8061-01	TCGA-FF-8061-01A-11D-2211-05	TCGA-FF-8061-01	TCGA-FF-8061-01A-11D-2209-01	TCGA-FF-8061-01	TCGA-FF-8061-01	TCGA-FF-8061-01A-11D-2209-01	TCGA-FF-8061-01A-11D-2210-10	953e90e7-a9a6-47d6-bd4a-fe18e780b9e0	27280077-9303-47C8-B3AA-51B5C4C66B35	953e90e7-a9a6-47d6-bd4a-fe18e780b9e0
TCGA-FF-8062-01	0	TCGA-FF-8062-01	679	0	days	TCGA-FF-8062	679	0	days	679	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	60		TCGA-FF-8062-F30774	TCGA-FF-8062	TCGA-FF-8062-01A		NO		Stage I	-21959			0	679		0				YES		1				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2012-1-17	FEMALE	FISH|FISH|FISH|FISH|	Normal|Normal|Normal|Normal|Normal	Normal|Normal|Normal|Normal|	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|IGK|IGL|	157	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No	Hepatitis B Virus	Negative	C83.3	9680/3	C73.9		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Negative|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|Cyclin D1	YES		0.9	NO	682	380	0.9			Thyroid	2.0	76 - 100%			NO		No	TCGA-FF-8062.cd5128c3-d5f8-4efb-acc3-ed3d6b8aae3f.pdf	8062	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01	0.5	7th	YES	YES	NO	FF	Thyroid	A	LIVING	60.1	2011	594f57f1-a1a9-4a3d-ae9e-fa601a29c917	594f57f1-a1a9-4a3d-ae9e-fa601a29c917	TCGA-FF-8062-01	TCGA-FF-8062-01A-11D-2211-05	TCGA-FF-8062-01	TCGA-FF-8062-01A-11D-2209-01	TCGA-FF-8062-01	TCGA-FF-8062-01	TCGA-FF-8062-01A-11D-2209-01	TCGA-FF-8062-01A-11D-2210-10	594f57f1-a1a9-4a3d-ae9e-fa601a29c917	85287531-553A-4096-B931-1F2BAFA9D262	594f57f1-a1a9-4a3d-ae9e-fa601a29c917
TCGA-FF-A7CQ-01	0	TCGA-FF-A7CQ-01	298	0	days	TCGA-FF-A7CQ	255	1	days	298	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	74		TCGA-FF-A7CQ-F50787	TCGA-FF-A7CQ	TCGA-FF-A7CQ-01A	YES	YES	Concordant Histology	Stage IV	-27255	1062		0	298	255	3				YES	bladder	6			NO	< or = 10%	Scheduled Follow-up Submission	Stable Disease	2014-9-18	MALE	FISH|FISH	Normal|Amplification|Normal|Normal	Normal|Normal	C-MYC|BCL2|BCL6|MALT1	PAX 5|IGH	162	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C77.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Negative|Negative|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|CD15|Cyclin D1	YES	70		NO	978	380		YES	Axillary|cervical|hilar|Iliac-common|Iliac-external|mediastinal|mesenteric|para-aortic|retroperitoneal|Splenic	Paratracheal/Mediastinal	3.4	51 - 75%	Brain		YES	false	No	TCGA-FF-A7CQ.3CCFB076-52BE-4A5D-9E49-65516AA9C349.pdf	A7CQ		Positive	Stable Disease	NO	Primary Tumor	01		7th	YES	NO	YES	FF	Adrenal|Bone|Bone Marrow|Liver|Pleura/Pleural Effusion|Other Extranodal Site	A	LIVING	43.9	2010	7c955c67-e0be-4c07-b0e9-b70da3a7f116	7c955c67-e0be-4c07-b0e9-b70da3a7f116	TCGA-FF-A7CQ-01	TCGA-FF-A7CQ-01A-11D-A383-05	TCGA-FF-A7CQ-01	TCGA-FF-A7CQ-01A-11D-A381-01	TCGA-FF-A7CQ-01	TCGA-FF-A7CQ-01	TCGA-FF-A7CQ-01A-11D-A381-01	TCGA-FF-A7CQ-01A-11D-A382-10	7c955c67-e0be-4c07-b0e9-b70da3a7f116		7c955c67-e0be-4c07-b0e9-b70da3a7f116
TCGA-FF-A7CR-01	1	TCGA-FF-A7CR-01	313	1	days	TCGA-FF-A7CR	290	1	days	313	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	61		TCGA-FF-A7CR-F50793	TCGA-FF-A7CR	TCGA-FF-A7CR-01A	NO	NO		Stage IV	-22471	464	313	0		290	0				YES		2	Diffuse Large B-Cell Lymphoma		YES	< or = 10%	Additional New Tumor Event	Progressive Disease	2013-10-30	MALE	FISH|FISH|FISH|FISH|	Normal|Normal|Normal|Normal|Normal	Normal|Translocation|Normal|Normal|	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX5|IGH|FoxP1|BCL10|	170	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No	Hepatitis C	Negative	C83.3	9680/3	C77.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|BCL6 > 30%|CD23|CD5|CD30|EBER|Cyclin D1	YES	360		NO	446	380		NO	Axillary|cervical|Inguinal|retroperitoneal	Cervical lymph nodes	3	0 - 25%	Other, specify	Skin (Calf and Chest wall)	YES	false	No	TCGA-FF-A7CR.C522C0BD-7968-48C0-8E96-6143740993E7.pdf	A7CR	WITH TUMOR	Not Done	Progressive Disease	NO	Primary Tumor	01		7th	YES	NO	YES	FF	Brain|Sinus	A	DECEASED	73	2012	bc8a3747-bd29-4388-94b9-74d92b6db3a3	bc8a3747-bd29-4388-94b9-74d92b6db3a3	TCGA-FF-A7CR-01	TCGA-FF-A7CR-01A-11D-A383-05	TCGA-FF-A7CR-01	TCGA-FF-A7CR-01A-11D-A381-01	TCGA-FF-A7CR-01	TCGA-FF-A7CR-01	TCGA-FF-A7CR-01A-11D-A381-01	TCGA-FF-A7CR-01A-11D-A382-10	bc8a3747-bd29-4388-94b9-74d92b6db3a3	8226E058-6678-4E67-AE03-88CA503D55B1	bc8a3747-bd29-4388-94b9-74d92b6db3a3
TCGA-FF-A7CW-01	0	TCGA-FF-A7CW-01	791	0	days	TCGA-FF-A7CW	791	0	days	791	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	72		TCGA-FF-A7CW-F59614	TCGA-FF-A7CW	TCGA-FF-A7CW-01A	YES	NO		Stage II	-26520	544		0	791		0				YES		1				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-5-16	MALE	FISH|FISH	Normal|Normal|Normal|Normal	Normal|Normal	C-MYC|BCL2|BCL6|MALT1	PAX5|IGH	154	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C77.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Negative|Positive|Negative|Negative|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|BCL6 > 30%|CD30|EBER|Cyclin D1	YES	230		NO	426	380		NO	cervical	Supraclavicular lymph nodes	2.1	51 - 75%			NO	false	No	TCGA-FF-A7CW.FF947398-211F-4ED6-A157-B86B7198B1B9.pdf	A7CW	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	NO	YES	FF	Parotid Gland	A	LIVING	51	2012	153f39e2-7b24-47c4-83ac-18a4f7441928	153f39e2-7b24-47c4-83ac-18a4f7441928	TCGA-FF-A7CW-01	TCGA-FF-A7CW-01A-11D-A383-05	TCGA-FF-A7CW-01	TCGA-FF-A7CW-01A-11D-A381-01	TCGA-FF-A7CW-01	TCGA-FF-A7CW-01	TCGA-FF-A7CW-01A-11D-A381-01	TCGA-FF-A7CW-01A-11D-A382-10	153f39e2-7b24-47c4-83ac-18a4f7441928	F97B961B-EBFF-42C1-8C90-FEFC0E35B82E	153f39e2-7b24-47c4-83ac-18a4f7441928
TCGA-FF-A7CX-01	0	TCGA-FF-A7CX-01	385	0	days	TCGA-FF-A7CX	385	0	days	385	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	46		TCGA-FF-A7CX-F50789	TCGA-FF-A7CX	TCGA-FF-A7CX-01A	YES	NO		Stage IV	-16924	747		0	385		0		EBER in situ hybridization	negative	YES		4				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2013-10-30	MALE	FISH|FISH|FISH	Normal|Normal|Normal|Normal|Normal	Normal|Normal|Normal	C-MYC|BCL2|BCL6|CCND1|MALT1	PAX 5|IGH|BCL10	174	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C49.0	9680/3	C49.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cytoplasmic Ig|EBER|Cyclin D1	YES	160		NO	714	380		YES	cervical	Lung	2.4	51 - 75%			NO	false	No	TCGA-FF-A7CX.7CABE1CC-F2F2-4B54-9568-DCFE2065C86B.pdf	A7CX	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	NO	YES	FF	Adrenal|Soft Tissue (muscle  ligaments  subcutaneous)|Brain|Thyroid|Lung	A	LIVING	66	2011	50f79ec5-c16a-4c56-909a-e32439b3ce2c	50f79ec5-c16a-4c56-909a-e32439b3ce2c	TCGA-FF-A7CX-01	TCGA-FF-A7CX-01A-12D-A383-05	TCGA-FF-A7CX-01	TCGA-FF-A7CX-01A-12D-A381-01	TCGA-FF-A7CX-01	TCGA-FF-A7CX-01	TCGA-FF-A7CX-01A-12D-A381-01	TCGA-FF-A7CX-01A-12D-A382-10	50f79ec5-c16a-4c56-909a-e32439b3ce2c	00476332-55DE-4045-B5C0-60FF4AE3C5B7	50f79ec5-c16a-4c56-909a-e32439b3ce2c
TCGA-FM-8000-01	0	TCGA-FM-8000-01	972	0	days	TCGA-FM-8000	972	0	days	972	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	70		TCGA-FM-8000-F64268	TCGA-FM-8000	TCGA-FM-8000-01A		NO	Discordant Histology	Stage II	-25724			0	972						YES		2				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-8-28	FEMALE						155.0	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Other	Diverticulitis requiring colectomy	None		No		Negative	C83.3	9680/3	C18.9		Flow cytometry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Negative|Positive|Positive|Positive|Positive|Negative	CD19|CD10 > 30%|CD20|MUM1 > 30%|BCL6 > 30%|CD23|PAX5|CD5|Cyclin D1	YES		0.6	NO	321	260	1	NO		Colon	12	26 - 50%			NO		No	TCGA-FM-8000.a30ee8fa-e177-458d-b0db-2637de27c3d7.pdf	8000	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01	0.4	7th	YES	YES	NO	FM	Colon|Small intestine	A	LIVING	69.5	2011	a35b6840-486a-4384-a714-48f1c4fe4f04	a35b6840-486a-4384-a714-48f1c4fe4f04	TCGA-FM-8000-01	TCGA-FM-8000-01A-11D-2211-05	TCGA-FM-8000-01	TCGA-FM-8000-01A-11D-2209-01	TCGA-FM-8000-01	TCGA-FM-8000-01	TCGA-FM-8000-01A-11D-2209-01	TCGA-FM-8000-01A-11D-2210-10	a35b6840-486a-4384-a714-48f1c4fe4f04	820C6BBB-9436-49F7-B47F-4CD9B9452243	a35b6840-486a-4384-a714-48f1c4fe4f04
TCGA-G8-6324-01	1	TCGA-G8-6324-01	1252	1	days	TCGA-G8-6324	338	1	days	1252	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	43	IgH PCR	TCGA-G8-6324-F37605	TCGA-G8-6324	TCGA-G8-6324-01A		YES	Discordant Histology	Stage IV	-15750		1252	0		338	1				YES		1			NO		Scheduled Follow-up Submission	Progressive Disease	2012-12-5	FEMALE		Normal|Normal|Normal		BCL2|BCL6|CCND1		165.5	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C77.2	Clonal	Flow cytometry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Positive|Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative	CD19|CD10 > 30%|BCL2|CD20|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD23|PAX5|CD5|CD5	YES		0.3	NO	498	618	0.6	NO	mesenteric			51 - 75%	Supraclavicular lymph nodes		YES		No	TCGA-G8-6324.d42f1d12-1281-4822-8342-a9b14729432a.pdf	6324	WITH TUMOR	Negative	Complete Remission/Response	NO	Primary Tumor	01	0.2	6th	YES	NO	YES	G8	Ascites/Peritoneum	A	DECEASED	60	2006	803db8de-5812-4dca-9e0e-aaa49096fd25	803db8de-5812-4dca-9e0e-aaa49096fd25	TCGA-G8-6324-01	TCGA-G8-6324-01A-11D-2211-05	TCGA-G8-6324-01	TCGA-G8-6324-01A-11D-2209-01	TCGA-G8-6324-01	TCGA-G8-6324-01	TCGA-G8-6324-01A-11D-2209-01	TCGA-G8-6324-01A-11D-2210-10	803db8de-5812-4dca-9e0e-aaa49096fd25		803db8de-5812-4dca-9e0e-aaa49096fd25
TCGA-G8-6325-01	0	TCGA-G8-6325-01	1581	0	days	TCGA-G8-6325	1581	0	days	1581	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	69	IgH PCR	TCGA-G8-6325-F40599	TCGA-G8-6325	TCGA-G8-6325-01A		NO		Stage IV	-25256			0	1581		1				NO		0					Scheduled Follow-up Submission	Stable Disease	2013-2-25	MALE						171	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Rheumatoid Arthritis|Other	Non-insulin dependent diabetes mellitus	Methotrexate		No		Negative	C83.3	9680/3	C77.2	Clonal	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD30	YES		0.4	NO		618	1	NO	retroperitoneal			51 - 75%			NO		No	TCGA-G8-6325.addc26cd-1381-4a9b-882a-e55287f791ef.pdf	6325	TUMOR FREE	Not Done	Stable Disease	NO	Primary Tumor	01	0.4	6th	YES	NO	YES	G8		A	LIVING	105.7	2008	05173547-1e4d-4a6d-ac36-9aaa92488a73	05173547-1e4d-4a6d-ac36-9aaa92488a73	TCGA-G8-6325-01	TCGA-G8-6325-01A-11D-2211-05	TCGA-G8-6325-01	TCGA-G8-6325-01A-11D-2209-01	TCGA-G8-6325-01	TCGA-G8-6325-01	TCGA-G8-6325-01A-11D-2209-01	TCGA-G8-6325-01A-11D-2210-10	05173547-1e4d-4a6d-ac36-9aaa92488a73	918C15AA-0B22-45FA-B10A-67F689815137	05173547-1e4d-4a6d-ac36-9aaa92488a73
TCGA-G8-6326-01	0	TCGA-G8-6326-01	2131	0	days	TCGA-G8-6326	2131	0	days	2131	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	52	IgH PCR	TCGA-G8-6326-F68655	TCGA-G8-6326	TCGA-G8-6326-01A		YES	Concordant Histology	Stage IV	-19238			0	2131		0		EBER in situ hybridization	negative	YES	Omentum	2					Scheduled Follow-up Submission	Complete Remission/Response	2014-12-5	MALE						185	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C48.1	9680/3	C48.1	Clonal	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Negative|Negative|Positive|Positive|Negative|Negative|Negative|Negative	CD10 > 30%|CD20|BCL6 > 30%|MUM1 > 30%|CD23|CD79a|PAX5|CD5|CD30|CD15|ALK	YES		0.5	NO	964	618	2.5	NO	mesenteric						NO		No	TCGA-G8-6326.3e506666-5cef-4416-9c02-1df6982b4ed1.pdf	6326	TUMOR FREE	Indeterminate	Progressive Disease	NO	Primary Tumor	01	0.4	6th	YES	NO	YES	G8	Ascites/Peritoneum|Other Extranodal Site	A	LIVING	127.7	2009	c66f6b85-0626-4e3a-8ec6-1cfc0a7def6b	c66f6b85-0626-4e3a-8ec6-1cfc0a7def6b	TCGA-G8-6326-01	TCGA-G8-6326-01A-11D-2211-05	TCGA-G8-6326-01	TCGA-G8-6326-01A-11D-2209-01	TCGA-G8-6326-01	TCGA-G8-6326-01	TCGA-G8-6326-01A-11D-2209-01	TCGA-G8-6326-01A-11D-2210-10	c66f6b85-0626-4e3a-8ec6-1cfc0a7def6b	91A967FA-0080-4BD3-AC2E-2096CEABE92A	c66f6b85-0626-4e3a-8ec6-1cfc0a7def6b
TCGA-G8-6906-01	1	TCGA-G8-6906-01	6425	1	days	TCGA-G8-6906	6383	1	days	6425	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	58	IgH Southern Blot	TCGA-G8-6906-F32214	TCGA-G8-6906	TCGA-G8-6906-01A		NO			-21272		6425	0		6383					YES	Spleen	1					Scheduled Follow-up Submission		2012-5-17	MALE						164.3	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					Yes		Negative	C83.3	9680/3	C77.2	Non-Clonal	Flow cytometry|Flow cytometry|Immunohistochemistry	Positive|Negative|Positive	CD19|CD10 > 30%|BCL2	YES		1	NO	325	185	1.1		para-aortic|retroperitoneal						YES		No	TCGA-G8-6906.78e17250-f41c-49af-8738-945cbba5c937.pdf	6906	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01	0.3		YES	NO	YES	G8	Other Extranodal Site	A	DECEASED	59.2	1987	a8ed4489-1005-488c-9e8e-274b2cfd8a83	a8ed4489-1005-488c-9e8e-274b2cfd8a83	TCGA-G8-6906-01	TCGA-G8-6906-01A-11D-2211-05	TCGA-G8-6906-01	TCGA-G8-6906-01A-11D-2209-01	TCGA-G8-6906-01	TCGA-G8-6906-01	TCGA-G8-6906-01A-11D-2209-01	TCGA-G8-6906-01A-11D-2210-10	a8ed4489-1005-488c-9e8e-274b2cfd8a83	68D7ED3A-B6C8-4278-A7B8-E27426A0EE79	a8ed4489-1005-488c-9e8e-274b2cfd8a83
TCGA-G8-6907-01	1	TCGA-G8-6907-01	595	1	days	TCGA-G8-6907			days	595	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	57	IgH Southern Blot		TCGA-G8-6907	TCGA-G8-6907-01A	YES	NO		Stage IV	-21021		595	0							NO		0							2012-5-17	FEMALE		Normal		BCL2		154.2	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C77.0	Non-Clonal	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive|Negative|Negative	CD10 > 30%|BCL2|CD20|CD23|CD5	YES		0.3	NO	628	618	0.5		cervical						YES		No	TCGA-G8-6907.47b6eb78-0dcf-4105-8cca-1835ecf8033d.pdf	6907	WITH TUMOR		Stable Disease	NO	Primary Tumor	01	0.1	5th	YES	NO	YES	G8		A	DECEASED	91.8	2000	5bce51af-fa6e-4fd2-b3b0-114eb8a275a9	5bce51af-fa6e-4fd2-b3b0-114eb8a275a9	TCGA-G8-6907-01	TCGA-G8-6907-01A-11D-2211-05	TCGA-G8-6907-01	TCGA-G8-6907-01A-11D-2209-01	TCGA-G8-6907-01	TCGA-G8-6907-01	TCGA-G8-6907-01A-11D-2209-01	TCGA-G8-6907-01A-11D-2210-10	5bce51af-fa6e-4fd2-b3b0-114eb8a275a9		5bce51af-fa6e-4fd2-b3b0-114eb8a275a9
TCGA-G8-6909-01	1	TCGA-G8-6909-01	3553	1	days	TCGA-G8-6909	3553	0	days	3553	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	67		TCGA-G8-6909-F43062	TCGA-G8-6909	TCGA-G8-6909-01A		NO		Stage III	-24661		3553	0	3227		0				NO		0					Scheduled Follow-up Submission	Complete Remission/Response	2013-5-9	MALE						178	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C77.1	9680/3	C77.1		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Negative|Positive|Negative|Negative|Negative|Negative	CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD23|CD5|CD30	YES		0.4	NO			0.4	NO	mediastinal						NO		No	TCGA-G8-6909.5e9ffc0b-63ad-4720-8c82-8850f3cc57eb.pdf	6909	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01	0.3	5th	YES	NO	YES	G8		A	DECEASED	90.5	2002	8c3c10a3-0fb4-4307-88ab-c8a99d0102cf	8c3c10a3-0fb4-4307-88ab-c8a99d0102cf	TCGA-G8-6909-01	TCGA-G8-6909-01A-11D-2211-05	TCGA-G8-6909-01	TCGA-G8-6909-01A-11D-2209-01	TCGA-G8-6909-01	TCGA-G8-6909-01	TCGA-G8-6909-01A-11D-2209-01	TCGA-G8-6909-01A-11D-2210-10	8c3c10a3-0fb4-4307-88ab-c8a99d0102cf		8c3c10a3-0fb4-4307-88ab-c8a99d0102cf
TCGA-G8-6914-01	0	TCGA-G8-6914-01	5980	0	days	TCGA-G8-6914	3669	1	days	5980	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	67		TCGA-G8-6914-F43065	TCGA-G8-6914	TCGA-G8-6914-01A		NO		Stage III	-24569			0	5980	3669					NO							Scheduled Follow-up Submission	Complete Remission/Response	2013-5-10	MALE						172	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C77.0		Flow cytometry|Flow cytometry|Flow cytometry	Positive|Positive|Positive	CD19|CD20|CD22	YES		0.8	NO			1.2	NO	cervical						YES		No	TCGA-G8-6914.db52dbf0-0988-4c64-abc5-6c38fe32da83.pdf	6914	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01	0.4	4th	YES	NO	YES	G8		A	LIVING	72.5	1996	d15202c0-099f-46c9-99c0-cc6bdf3e82b1	d15202c0-099f-46c9-99c0-cc6bdf3e82b1	TCGA-G8-6914-01	TCGA-G8-6914-01A-11D-2211-05	TCGA-G8-6914-01	TCGA-G8-6914-01A-11D-2209-01	TCGA-G8-6914-01	TCGA-G8-6914-01	TCGA-G8-6914-01A-11D-2209-01	TCGA-G8-6914-01A-11D-2210-10	d15202c0-099f-46c9-99c0-cc6bdf3e82b1	ED9F2B1A-05BC-442A-8ED5-BBEE278E2817	d15202c0-099f-46c9-99c0-cc6bdf3e82b1
TCGA-GR-7351-01	0	TCGA-GR-7351-01	4578	0	days	TCGA-GR-7351	4578	0	days	4578	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	56		TCGA-GR-7351-F55516	TCGA-GR-7351	TCGA-GR-7351-01A	YES	NO		Stage I	-20812			0	4578		1				YES		1				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-7-1	FEMALE						166.5	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Hashimotos Thyroiditis		None		No			C83.3	9680/3	C73.9		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive	CD10 > 30%|CD20|BCL6 > 30%	YES		0	NO	498	618	0.1	NO		Thyroid	5.5				NO		No	TCGA-GR-7351.32fa61f2-a17b-40da-b80d-1338a7bb9a7d.pdf	7351	TUMOR FREE	Negative	Complete Remission/Response	YES	Primary Tumor	01	0		YES	NO	YES	GR	Thyroid	A	LIVING	77.5	2001	9105777f-ef5a-4455-a762-52923fa38924	9105777f-ef5a-4455-a762-52923fa38924	TCGA-GR-7351-01	TCGA-GR-7351-01A-11D-2211-05		TCGA-GR-7351-01A-11D-2209-01	TCGA-GR-7351-01		TCGA-GR-7351-01A-11D-2209-01	TCGA-GR-7351-01A-11D-2210-10	9105777f-ef5a-4455-a762-52923fa38924		9105777f-ef5a-4455-a762-52923fa38924
TCGA-GR-7353-01	0	TCGA-GR-7353-01	2983	0	days	TCGA-GR-7353	2983	0	days	2983	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	36		TCGA-GR-7353-F55519	TCGA-GR-7353		YES	NO		Stage II	-13317			0	2983		1				NO		0				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-7-1	MALE						171.5	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					No			C83.3	9680/3	C77.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Positive|Negative|Negative	CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD5|Cyclin D1	YES				164	250		NO	cervical	Cervical lymph nodes	4.4				NO		No		7353	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01			YES	NO	YES	GR			LIVING	68.0	2005	e8483323-cee6-48ca-bc8d-e7b2f9e0707b	e8483323-cee6-48ca-bc8d-e7b2f9e0707b	TCGA-GR-7353-01	TCGA-GR-7353-01A-11D-2211-05	TCGA-GR-7353-01	TCGA-GR-7353-01A-11D-2209-01	TCGA-GR-7353-01	TCGA-GR-7353-01	TCGA-GR-7353-01A-11D-2209-01	TCGA-GR-7353-01A-11D-2210-10	e8483323-cee6-48ca-bc8d-e7b2f9e0707b		e8483323-cee6-48ca-bc8d-e7b2f9e0707b
TCGA-GR-A4D4-01	0	TCGA-GR-A4D4-01	1581	0	days	TCGA-GR-A4D4	1581	0	days	1581	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	57		TCGA-GR-A4D4-F68696	TCGA-GR-A4D4		YES	NO		Stage IV	-20888			0	1581		2				YES		2				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-12-11	FEMALE						168.0	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					No			C83.3	9680/3	C49.9		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive|Negative|Positive|Positive|Negative|Negative|Negative|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|PAX5|CD5|CD30|EBER|ALK	YES				143	192		NO		Soft Tissue (muscle, ligaments, subcutaneous)	5.4				NO		No		A4D4	TUMOR FREE	Indeterminate	Complete Remission/Response	NO	Primary Tumor	01			YES	NO	YES	GR	Bone|Soft Tissue (muscle  ligaments  subcutaneous)		LIVING	76.1	2010	c6930a35-3476-46a0-adde-da76ee758390	c6930a35-3476-46a0-adde-da76ee758390	TCGA-GR-A4D4-01	TCGA-GR-A4D4-01A-11D-A31Y-05	TCGA-GR-A4D4-01	TCGA-GR-A4D4-01A-11D-A31W-01	TCGA-GR-A4D4-01	TCGA-GR-A4D4-01	TCGA-GR-A4D4-01A-11D-A31W-01	TCGA-GR-A4D4-01A-11D-A31X-10	c6930a35-3476-46a0-adde-da76ee758390		c6930a35-3476-46a0-adde-da76ee758390
TCGA-GR-A4D5-01	0	TCGA-GR-A4D5-01	1299	0	days	TCGA-GR-A4D5	1299	0	days	1299	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	46		TCGA-GR-A4D5-F55579	TCGA-GR-A4D5	TCGA-GR-A4D5-01A	YES	NO		Stage IV	-17023	852		0	1299		1				YES		3				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-7-1	FEMALE						159.5	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					No		Negative	C83.3	9680/3	C77.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|CD30|CD15	YES	1		NO	851	618		NO	Axillary|cervical|Inguinal|mesenteric|supraclavicular	Cervical lymph nodes	4.5				NO	false	No	TCGA-GR-A4D5.97EAEC1D-1C5A-4FE8-8D2B-80DD433DB18C.pdf	A4D5	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01			YES	NO	YES	GR	Bone|Skin|Soft Tissue (muscle  ligaments  subcutaneous)	A	LIVING	117.1	2010	0e814275-e5f4-4071-a65f-58eac29774ee	0e814275-e5f4-4071-a65f-58eac29774ee	TCGA-GR-A4D5-01	TCGA-GR-A4D5-01A-11D-A31Y-05	TCGA-GR-A4D5-01	TCGA-GR-A4D5-01A-11D-A31W-01	TCGA-GR-A4D5-01	TCGA-GR-A4D5-01	TCGA-GR-A4D5-01A-11D-A31W-01	TCGA-GR-A4D5-01A-11D-A31X-10	0e814275-e5f4-4071-a65f-58eac29774ee		0e814275-e5f4-4071-a65f-58eac29774ee
TCGA-GR-A4D6-01	0	TCGA-GR-A4D6-01	1334	0	days	TCGA-GR-A4D6	1334	0	days	1334	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	54		TCGA-GR-A4D6-F55581	TCGA-GR-A4D6	TCGA-GR-A4D6-01A	YES	NO		Stage I	-19838	880		0	1334		0				NO		0				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-7-1	FEMALE						155.0	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					No			C83.3	9680/3	C77.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Positive|Positive|Positive|Positive|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5	YES	1		NO	120	192		NO	cervical	Cervical lymph nodes	2.7				NO	false	No	TCGA-GR-A4D6.ABBC803D-EFC5-4223-8309-0F06F6AAAF9E.pdf	A4D6	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01			YES	NO	YES	GR		A	LIVING	54.5	2010	01dbc8b9-99eb-4bb7-8c90-6fae272ebf63	01dbc8b9-99eb-4bb7-8c90-6fae272ebf63	TCGA-GR-A4D6-01	TCGA-GR-A4D6-01A-11D-A31Y-05	TCGA-GR-A4D6-01	TCGA-GR-A4D6-01A-11D-A31W-01	TCGA-GR-A4D6-01	TCGA-GR-A4D6-01	TCGA-GR-A4D6-01A-11D-A31W-01	TCGA-GR-A4D6-01A-11D-A31X-10	01dbc8b9-99eb-4bb7-8c90-6fae272ebf63		01dbc8b9-99eb-4bb7-8c90-6fae272ebf63
TCGA-GR-A4D9-01	0	TCGA-GR-A4D9-01	1739	0	days	TCGA-GR-A4D9	1218	1	days	1739	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	66		TCGA-GR-A4D9-F55583	TCGA-GR-A4D9	TCGA-GR-A4D9-01B	YES	NO		Stage IV	-24405	1289		0	1739	1218	1				YES		3	Other Histological Type	Composite Lymphoma: B-FL-3A (60%) & B-DLCL-NC (40%)	YES	< or = 10%	Scheduled Follow-up Submission	Progressive Disease	2014-7-1	FEMALE						164.7	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Other	Common variable immunodeficiency	Other	Immunoglobulin	No			C83.3	9680/3	C77.0		Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Negative|Positive|Positive|Positive|Negative|Negative|Negative	CD19|CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD5|EBER	YES	1		NO	420	618		NO	Axillary|cervical|hilar|Iliac-common|Iliac-external|Inguinal|mediastinal|retroperitoneal|supraclavicular	Cervical lymph nodes	7.0		Soft Tissue		YES	false	No	TCGA-GR-A4D9.F4DE97A1-D58D-431F-8C93-8F0647F2F493.pdf	A4D9	WITH TUMOR	Not Done	Complete Remission/Response	NO	Primary Tumor	01			YES	NO	YES	GR	Soft Tissue (muscle  ligaments  subcutaneous)|Lung|Pleura/Pleural Effusion	B	LIVING	96.8	2009	19aaa769-e404-4ecc-9e39-e07bfc9ba89c	19aaa769-e404-4ecc-9e39-e07bfc9ba89c	TCGA-GR-A4D9-01	TCGA-GR-A4D9-01B-11D-A31Y-05	TCGA-GR-A4D9-01	TCGA-GR-A4D9-01B-11D-A31W-01	TCGA-GR-A4D9-01	TCGA-GR-A4D9-01	TCGA-GR-A4D9-01B-11D-A31W-01	TCGA-GR-A4D9-01B-11D-A31X-10	19aaa769-e404-4ecc-9e39-e07bfc9ba89c		19aaa769-e404-4ecc-9e39-e07bfc9ba89c
TCGA-GS-A9TQ-01	0	TCGA-GS-A9TQ-01	982	0	days	TCGA-GS-A9TQ	982	0	days	982	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	69		TCGA-GS-A9TQ-F72118	TCGA-GS-A9TQ	TCGA-GS-A9TQ-01A	YES	NO		Stage II	-25292	549		0	982		1				NO		0				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2015-4-16	FEMALE		Gain		C-MYC		155	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C77.4		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Flow cytometry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Positive|Positive|Positive|Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative|Indeterminate|Positive	CD10 > 30%|BCL2|CD20|CD138|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD19|P53 >20%|MUM1 > 30%|Cytoplasmic Ig|Surface Ig	YES	90		NO	364	450		NO	Femoral|Inguinal	Inguinal	3	76 - 100%			NO	true	No	TCGA-GS-A9TQ.FA3E9D38-9A2D-43EC-AEBD-DDDA323F8BB2.pdf	A9TQ	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	NO	YES	GS		A	LIVING	68	2012	827ebf10-230a-442b-aaae-80e1e0210bb5	827ebf10-230a-442b-aaae-80e1e0210bb5	TCGA-GS-A9TQ-01	TCGA-GS-A9TQ-01A-11D-A383-05	TCGA-GS-A9TQ-01	TCGA-GS-A9TQ-01A-11D-A381-01	TCGA-GS-A9TQ-01	TCGA-GS-A9TQ-01	TCGA-GS-A9TQ-01A-11D-A381-01	TCGA-GS-A9TQ-01A-11D-A382-10	827ebf10-230a-442b-aaae-80e1e0210bb5		827ebf10-230a-442b-aaae-80e1e0210bb5
TCGA-GS-A9TT-01	0	TCGA-GS-A9TT-01	1163	0	days	TCGA-GS-A9TT	1163	0	days	1163	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	70		TCGA-GS-A9TT-F66756	TCGA-GS-A9TT	TCGA-GS-A9TT-01A	YES	NO		Stage IV	-25794	902		0	1163		1		EBER in situ hybridization	negative	YES		2				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-11-6	MALE						169	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C62.90	9680/3	C62.9		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry|Flow cytometry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Negative|Positive|Positive|Negative|Positive|Positive|Positive|Positive|Negative	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD79a|CD5|CD19|CD22|Cytoplasmic Ig|Surface Ig|EBER	YES	130		NO	756	450		NO	Axillary|para-aortic|Splenic|supraclavicular		3	76 - 100%			NO	true	No	TCGA-GS-A9TT.7F403F75-9100-4C68-8F36-14AD78B954FD.pdf	A9TT	TUMOR FREE	Negative	Complete Remission/Response	YES	Primary Tumor	01		7th	YES	NO	YES	GS	Bone|Testes	A	LIVING	85	2011	defc682b-c70e-40b5-9d8b-3dd146bc7c0e	defc682b-c70e-40b5-9d8b-3dd146bc7c0e	TCGA-GS-A9TT-01	TCGA-GS-A9TT-01A-11D-A383-05	TCGA-GS-A9TT-01	TCGA-GS-A9TT-01A-11D-A381-01	TCGA-GS-A9TT-01	TCGA-GS-A9TT-01	TCGA-GS-A9TT-01A-11D-A381-01	TCGA-GS-A9TT-01A-11D-A382-10	defc682b-c70e-40b5-9d8b-3dd146bc7c0e	642A415A-E623-4A18-BD32-18E304F262B8	defc682b-c70e-40b5-9d8b-3dd146bc7c0e
TCGA-GS-A9TU-01	0	TCGA-GS-A9TU-01	3897	0	days	TCGA-GS-A9TU	3897	0	days	3897	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	45	IgH PCR	TCGA-GS-A9TU-F70366	TCGA-GS-A9TU		NO			Stage II	-16720			0	3897		1				NO		0				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-10	MALE		Normal		BCL2		183	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					No		Negative	C83.3	9680/3	C77.4	Non-Clonal	Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Positive|Negative|Positive|Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Positive	CD19|CD10 > 30%|BCL2|P53 >20%|CD20|MUM1 > 30%|CD22|BCL6 > 30%|CD23|CD79a|CD5|Cytoplasmic Ig	YES				337	450		NO	Inguinal		2	51 - 75%			NO		No		A9TU	TUMOR FREE	Negative	Complete Remission/Response	YES	Primary Tumor	01		6th	YES	NO	YES	GS			LIVING	90	2004	fbe73185-19de-4d0e-af7c-589ca5ffebf6	fbe73185-19de-4d0e-af7c-589ca5ffebf6	TCGA-GS-A9TU-01	TCGA-GS-A9TU-01A-11D-A383-05	TCGA-GS-A9TU-01	TCGA-GS-A9TU-01A-11D-A381-01	TCGA-GS-A9TU-01	TCGA-GS-A9TU-01	TCGA-GS-A9TU-01A-11D-A381-01	TCGA-GS-A9TU-01A-11D-A382-10	fbe73185-19de-4d0e-af7c-589ca5ffebf6		fbe73185-19de-4d0e-af7c-589ca5ffebf6
TCGA-GS-A9TV-01	0	TCGA-GS-A9TV-01	730	0	days	TCGA-GS-A9TV	730	0	days	730	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	40		TCGA-GS-A9TV-F70367	TCGA-GS-A9TV	TCGA-GS-A9TV-01A	YES	NO		Stage II	-14838	339		0	730		0		EBER in situ hybridization	negative	NO		0				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-10	FEMALE						160	Primary mediastinal (thymic) DLBCL					No		Negative	C83.3	9680/3	C77.0		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Positive|Positive|Positive|Positive|Negative|Negative|Negative|Indeterminate|Indeterminate	CD20|CD23|PAX5|CD30|CD15|EBER|CD5|Cytoplasmic Ig|Surface Ig	YES	100		NO		450		NO	cervical|mediastinal|para-aortic|supraclavicular	mediastinal	5	26 - 50%			NO	true	No	TCGA-GS-A9TV.2197BDCD-266C-4256-A18A-D0E8EAA63518.pdf	A9TV	TUMOR FREE	Negative	Complete Remission/Response	YES	Primary Tumor	01		7th	YES	NO	YES	GS		A	LIVING	58	2013	fe20123e-6e24-4900-97b1-60965fe89c8c	fe20123e-6e24-4900-97b1-60965fe89c8c	TCGA-GS-A9TV-01	TCGA-GS-A9TV-01A-11D-A383-05	TCGA-GS-A9TV-01	TCGA-GS-A9TV-01A-11D-A381-01	TCGA-GS-A9TV-01	TCGA-GS-A9TV-01	TCGA-GS-A9TV-01A-11D-A381-01	TCGA-GS-A9TV-01A-11D-A382-10	fe20123e-6e24-4900-97b1-60965fe89c8c	ADCD23CD-27CE-4B8A-9BF2-D203F0C8AA1D	fe20123e-6e24-4900-97b1-60965fe89c8c
TCGA-GS-A9TW-01	0	TCGA-GS-A9TW-01	1617	0	days	TCGA-GS-A9TW	1617	0	days	1617	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	23		TCGA-GS-A9TW-F70368	TCGA-GS-A9TW	TCGA-GS-A9TW-01A	YES	NO		Stage II	-8493	1255		0	1617		0		EBER in situ hybridization	negative	NO		0				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-10	FEMALE						165	Primary mediastinal (thymic) DLBCL					No		Negative	C83.3	9680/3	C77.3		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Negative|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative|Indeterminate|Indeterminate	CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD79a|CD30|CD15|EBER|CD5|Cytoplasmic Ig|Surface Ig	YES	190		NO	252	450		NO	Axillary|cervical|mediastinal|para-aortic	mediastinal	4	76 - 100%			NO	true	No	TCGA-GS-A9TW.2D2E6687-CD36-42F1-A091-7B249A2FAFF6.pdf	A9TW	TUMOR FREE	Negative	Complete Remission/Response	YES	Primary Tumor	01		7th	YES	NO	YES	GS		A	LIVING	54	2010	64585cbf-917f-4d28-8b42-b085e7cd7e67	64585cbf-917f-4d28-8b42-b085e7cd7e67	TCGA-GS-A9TW-01	TCGA-GS-A9TW-01A-11D-A383-05	TCGA-GS-A9TW-01	TCGA-GS-A9TW-01A-11D-A381-01	TCGA-GS-A9TW-01	TCGA-GS-A9TW-01	TCGA-GS-A9TW-01A-11D-A381-01	TCGA-GS-A9TW-01A-11D-A382-10	64585cbf-917f-4d28-8b42-b085e7cd7e67	4A184274-82EA-4325-A1BA-9BDA4A224372	64585cbf-917f-4d28-8b42-b085e7cd7e67
TCGA-GS-A9TX-01	0	TCGA-GS-A9TX-01	1373	0	days	TCGA-GS-A9TX	1373	0	days	1373	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	37		TCGA-GS-A9TX-F72119	TCGA-GS-A9TX	TCGA-GS-A9TX-01A	YES	NO		Stage I	-13708	919		0	1373		0				NO		0				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2015-4-16	MALE	FISH|	Normal|Gain	Loss|	BCL2|BCL6	1p36|	187	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					No		Negative	C83.3	9680/3	C77.4		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry	Positive|Positive|Negative|Negative|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Positive|Positive	CD19|CD10 > 30%|BCL2|P53 >20%|CD20|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD30|Cytoplasmic Ig|Surface Ig	YES	360		NO	257	450		NO	Inguinal		.42	51 - 75%			NO	true	No	TCGA-GS-A9TX.B7674358-B4F0-4348-954A-E6A2CBD9C076.pdf	A9TX	TUMOR FREE	Negative	Complete Remission/Response	YES	Primary Tumor	01		7th	YES	NO	YES	GS		A	LIVING	85	2011	17b87815-5cb8-49c1-a09f-d3e99a6c19c1	17b87815-5cb8-49c1-a09f-d3e99a6c19c1	TCGA-GS-A9TX-01	TCGA-GS-A9TX-01A-11D-A383-05	TCGA-GS-A9TX-01	TCGA-GS-A9TX-01A-11D-A381-01	TCGA-GS-A9TX-01	TCGA-GS-A9TX-01	TCGA-GS-A9TX-01A-11D-A381-01	TCGA-GS-A9TX-01A-11D-A382-10	17b87815-5cb8-49c1-a09f-d3e99a6c19c1	500B2B8B-F857-4768-A9E3-C769A720BA1F	17b87815-5cb8-49c1-a09f-d3e99a6c19c1
TCGA-GS-A9TY-01	0	TCGA-GS-A9TY-01	3333	0	days	TCGA-GS-A9TY	3255	1	days	3333	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	82		TCGA-GS-A9TY-F66822	TCGA-GS-A9TY	TCGA-GS-A9TY-01A	NO			Stage I	-30256	3053		0	3333	3255	1				NO		0			NO	< or = 10%	Scheduled Follow-up Submission	Progressive Disease	2014-11-6	FEMALE		Normal		BCL2		153	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					No		Negative	C83.3	9680/3	C77.3		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Negative|Positive|Positive|Negative|Positive|Negative|Indeterminate	CD10 > 30%|BCL2|P53 >20%|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cytoplasmic Ig	YES	20		NO	288	450		NO	Axillary		1	51 - 75%	Pleura/Pleural effusion		YES	true	No	TCGA-GS-A9TY.E7D2AFFA-14B9-436F-B76F-C1F5B88D7600.pdf	A9TY	WITH TUMOR	Negative	Complete Remission/Response	NO	Primary Tumor	01		6th	YES	NO	YES	GS		A	LIVING	77	2005	2cb30421-0335-4427-801d-221735b9beec	2cb30421-0335-4427-801d-221735b9beec	TCGA-GS-A9TY-01	TCGA-GS-A9TY-01A-11D-A39G-05	TCGA-GS-A9TY-01	TCGA-GS-A9TY-01A-11D-A38W-01	TCGA-GS-A9TY-01	TCGA-GS-A9TY-01	TCGA-GS-A9TY-01A-11D-A38W-01	TCGA-GS-A9TY-01A-11D-A38X-10	2cb30421-0335-4427-801d-221735b9beec		2cb30421-0335-4427-801d-221735b9beec
TCGA-GS-A9TZ-01	0	TCGA-GS-A9TZ-01	765	0	days	TCGA-GS-A9TZ	765	0	days	765	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	51		TCGA-GS-A9TZ-F70392	TCGA-GS-A9TZ	TCGA-GS-A9TZ-01A	YES	NO		Stage II	-18691	381		0	765		0		EBER in situ hybridization	negative	NO		0				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-11	MALE	Cytogenetics		Normal		G Band Karyotype	168	Primary mediastinal (thymic) DLBCL					No		Negative	C83.3	9680/3	C77.0		Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry	Positive|Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative|Positive|Indeterminate|Indeterminate	CD19|CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD15|EBER|CD30|Cytoplasmic Ig|Surface Ig	YES	120		NO		450		YES	cervical|mediastinal|supraclavicular	mediastinal	17	51 - 75%			NO	true	No	TCGA-GS-A9TZ.9A705521-237B-429B-B4F6-5CBF2854E252.pdf	A9TZ	TUMOR FREE	Negative	Partial Remission/Response	YES	Primary Tumor	01		7th	YES	NO	YES	GS		A	LIVING	68	2012	9a66e6e2-7888-47c8-9655-9952d9ac546f	9a66e6e2-7888-47c8-9655-9952d9ac546f	TCGA-GS-A9TZ-01	TCGA-GS-A9TZ-01A-11D-A39G-05	TCGA-GS-A9TZ-01	TCGA-GS-A9TZ-01A-11D-A38W-01	TCGA-GS-A9TZ-01	TCGA-GS-A9TZ-01	TCGA-GS-A9TZ-01A-11D-A38W-01	TCGA-GS-A9TZ-01A-11D-A38X-10	9a66e6e2-7888-47c8-9655-9952d9ac546f	B6990D20-62D2-4156-B58E-4283A706866F	9a66e6e2-7888-47c8-9655-9952d9ac546f
TCGA-GS-A9U3-01	0	TCGA-GS-A9U3-01	3394	0	days	TCGA-GS-A9U3	3394	0	days	3394	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	77		TCGA-GS-A9U3-F70370	TCGA-GS-A9U3		YES	NO		Stage III	-28474			0	3394		1				NO						< or = 10%	Scheduled Follow-up Submission		2015-2-10	FEMALE		Translocation		BCL2		157	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)					No		Negative	C83.3	9680/3	C77.4		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry	Negative|Positive|Positive|Negative|Negative|Positive|Negative|Negative|Positive|Positive	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD22|CD5|CD30|Cytoplasmic Ig|Surface Ig	YES				391	450		YES	hilar|Iliac-common|Inguinal|para-aortic|Splenic		3	51 - 75%			NO		No		A9U3	TUMOR FREE	Negative	Complete Remission/Response	NO	Primary Tumor	01		6th	YES	NO	YES	GS			LIVING	80	2005	c1067d6d-aaa2-4d8b-b243-6bb625980a4b	c1067d6d-aaa2-4d8b-b243-6bb625980a4b	TCGA-GS-A9U3-01	TCGA-GS-A9U3-01A-11D-A39G-05	TCGA-GS-A9U3-01	TCGA-GS-A9U3-01A-11D-A38W-01	TCGA-GS-A9U3-01	TCGA-GS-A9U3-01	TCGA-GS-A9U3-01A-11D-A38W-01	TCGA-GS-A9U3-01A-11D-A38X-10	c1067d6d-aaa2-4d8b-b243-6bb625980a4b		c1067d6d-aaa2-4d8b-b243-6bb625980a4b
TCGA-GS-A9U4-01	1	TCGA-GS-A9U4-01	391	1	days	TCGA-GS-A9U4	106	1	days	391	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	27	IgH PCR	TCGA-GS-A9U4-F66825	TCGA-GS-A9U4	TCGA-GS-A9U4-01A	YES	NO		Stage II	-10075	806	391	0		106	0	80	EBER in situ hybridization	positive	NO		0			NO	< or = 10%	Scheduled Follow-up Submission	Progressive Disease	2014-11-6	FEMALE		Loss		C-MYC		163	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Other	Behgets disease	Azathioprine|Other	Prednisone	No		Negative	C83.3	9680/3	C77.0	Clonal	Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive|Positive|Negative|Positive|Negative|Positive|Negative|Positive|Negative|Indeterminate	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD79a|CD5|CD30|CD15|EBER|ALK|Cytoplasmic Ig	YES	310		NO	385	450		NO	supraclavicular|Submandibular		3	51 - 75%	Cervical Lymph Nodes		YES	true	No	TCGA-GS-A9U4.599B4A65-9372-43BC-9236-0C49CD264979.pdf	A9U4	WITH TUMOR	Not Done	Progressive Disease	NO	Primary Tumor	01		7th	YES	NO	YES	GS		A	DECEASED	50	2011	f89496fe-9413-4038-8e9c-c586ae83d0e1	f89496fe-9413-4038-8e9c-c586ae83d0e1	TCGA-GS-A9U4-01	TCGA-GS-A9U4-01A-11D-A39G-05	TCGA-GS-A9U4-01	TCGA-GS-A9U4-01A-11D-A38W-01	TCGA-GS-A9U4-01	TCGA-GS-A9U4-01	TCGA-GS-A9U4-01A-11D-A38W-01	TCGA-GS-A9U4-01A-11D-A38X-10	f89496fe-9413-4038-8e9c-c586ae83d0e1	B27DB265-1E06-4BD3-BC77-F5BA80C0EC4C	f89496fe-9413-4038-8e9c-c586ae83d0e1
TCGA-RQ-A68N-01	0	TCGA-RQ-A68N-01	788	0	days	TCGA-RQ-A68N	788	0	days	788	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	63		TCGA-RQ-A68N-F64642	TCGA-RQ-A68N	TCGA-RQ-A68N-01A	YES	NO			-23127	461		0	788								3				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2014-9-9	MALE						162	Primary DLBCL of the CNS					No			C71.7	9680/3	C71.7		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry	Negative|Positive|Positive	CD10 > 30%|BCL2|CD20	YES	150		NO				NO	other						NO	true	No	TCGA-RQ-A68N.B40907C0-DA7B-436F-993A-53DA4C9A56A9.pdf	A68N	TUMOR FREE	Not Done	Complete Remission/Response	NO	Primary Tumor	01		7th	YES	NO	YES	RQ	Brain	A	LIVING	58	2012	daf79c8a-16b5-4d69-aaad-93d25ddcaac4	daf79c8a-16b5-4d69-aaad-93d25ddcaac4	TCGA-RQ-A68N-01	TCGA-RQ-A68N-01A-11D-A31Y-05	TCGA-RQ-A68N-01	TCGA-RQ-A68N-01A-11D-A31W-01	TCGA-RQ-A68N-01	TCGA-RQ-A68N-01	TCGA-RQ-A68N-01A-11D-A31W-01	TCGA-RQ-A68N-01A-11D-A31X-10	daf79c8a-16b5-4d69-aaad-93d25ddcaac4	CC440064-46B5-4FC7-B1FA-5EC610CC066B	daf79c8a-16b5-4d69-aaad-93d25ddcaac4
TCGA-RQ-A6JB-01	0	TCGA-RQ-A6JB-01	1	0	days	TCGA-RQ-A6JB			days	1	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	62		TCGA-RQ-A6JB-F68331	TCGA-RQ-A6JB	TCGA-RQ-A6JB-01A					-22859	541		0	1						YES		3				< or = 10%	Scheduled Follow-up Submission		2014-11-14	FEMALE						167	Primary DLBCL of the CNS			None		No		Negative	C83.3	9680/3	C41.0					YES	370		NO				YES	other							true	No	TCGA-RQ-A6JB.0250A7AA-A53D-4DCB-BF74-04FABD979B25.pdf	A6JB					Primary Tumor	01		7th		NO	YES	RQ	Bone|Skin|Soft Tissue (muscle  ligaments  subcutaneous)	A	LIVING	72	2011	2b22fd4d-014d-441f-a4d3-1502f03e931c	2b22fd4d-014d-441f-a4d3-1502f03e931c	TCGA-RQ-A6JB-01	TCGA-RQ-A6JB-01A-11D-A31Y-05	TCGA-RQ-A6JB-01	TCGA-RQ-A6JB-01A-11D-A31W-01	TCGA-RQ-A6JB-01	TCGA-RQ-A6JB-01	TCGA-RQ-A6JB-01A-11D-A31W-01	TCGA-RQ-A6JB-01A-11D-A31X-10	2b22fd4d-014d-441f-a4d3-1502f03e931c	1263085D-5F47-4802-BF56-D31EC61C301B	2b22fd4d-014d-441f-a4d3-1502f03e931c
TCGA-RQ-AAAT-01	0	TCGA-RQ-AAAT-01	17	0	days	TCGA-RQ-AAAT	17	0	days	17	days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	63		TCGA-RQ-AAAT-F64663	TCGA-RQ-AAAT	TCGA-RQ-AAAT-01A					-23178	186		0	17								1				< or = 10%	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-23	FEMALE						162.5	Primary DLBCL of the CNS					No		Negative	C71.6	9680/3	C71.6		Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|	Positive|Negative|Positive|Positive|Positive|Negative|	CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD30|	YES	90		NO				YES	other	Posterior Fossa	1.8	76 - 100%			NO	false	No	TCGA-RQ-AAAT.66B90AE3-785B-4866-8B56-7B3B37EF38B5.pdf	AAAT	TUMOR FREE		Complete Remission/Response	NO	Primary Tumor	01		7th	NO	NO	YES	RQ	Brain	A	LIVING	68.2	2013	7f531556-60c1-482c-9c1d-4a9ab00c7eac	7f531556-60c1-482c-9c1d-4a9ab00c7eac	TCGA-RQ-AAAT-01	TCGA-RQ-AAAT-01A-11D-A39G-05	TCGA-RQ-AAAT-01	TCGA-RQ-AAAT-01A-11D-A38W-01	TCGA-RQ-AAAT-01	TCGA-RQ-AAAT-01	TCGA-RQ-AAAT-01A-11D-A38W-01	TCGA-RQ-AAAT-01A-11D-A38X-10	7f531556-60c1-482c-9c1d-4a9ab00c7eac		7f531556-60c1-482c-9c1d-4a9ab00c7eac
TCGA-VB-A8QN-01		TCGA-VB-A8QN-01			days	TCGA-VB-A8QN			days		days	TCGA Large B-cell Lymphoma (DLBC)	diffuse large B-cell lymphoma	Lymphatic tissue	55		TCGA-VB-A8QN-F56126	TCGA-VB-A8QN	TCGA-VB-A8QN-01A				Stage III	-20270	256		0	0						YES							Scheduled Follow-up Submission		2014-11-11	MALE						180	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)			None		No		Negative	C83.3	9680/3	C16.9					YES	1390		NO				YES	other		10				NO	false	No	TCGA-VB-A8QN.A661F75B-6FD2-4294-8103-969308EFF4EF.pdf	A8QN	TUMOR FREE			NO	Primary Tumor	01		7th	NO	YES	NO	VB	Stomach	A	LIVING	75	2013	9602264c-a350-4e8b-84f0-07f5710e1f24	9602264c-a350-4e8b-84f0-07f5710e1f24	TCGA-VB-A8QN-01	TCGA-VB-A8QN-01A-11D-A383-05	TCGA-VB-A8QN-01	TCGA-VB-A8QN-01A-11D-A381-01	TCGA-VB-A8QN-01	TCGA-VB-A8QN-01	TCGA-VB-A8QN-01A-11D-A381-01	TCGA-VB-A8QN-01A-11D-A382-10	9602264c-a350-4e8b-84f0-07f5710e1f24	888126C6-C3B9-4619-BA53-BA484E69AD7C	9602264c-a350-4e8b-84f0-07f5710e1f24
